Putting together a PowerPoint presentation looks like the simple matter of choosing a template, typing up some bullet points, adding a few graphs and a bit of clip art, and calling your project ...

New data from the Phase 1/1b ARC-20 cohort evaluating HIF-2a inhibitor casdatifan in combination with cabozantinib in clear cell renal cell carcinoma (ccRCC) will be presented in an oral session by Dr ...

4 IDEAYA/GSK presentations of IDE275 (GSK959) and 4 additional presentations across IDE397/MAT2A, IDE161/PARG, PRMT5, and KAT6/7 programs at AACR 2025 IDE275 (GSK959) has demonstrated a potential best ...

Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that Phase 1/2 interim results from its U.S. NXC-201 ...

BioChaperone® is a proprietary platform tailored to solve peptide formulation issues by means of non-covalent molecular complexation. The oral presentation at the PODD (Partnership Opportunities in ...

Whether you are a seasoned speaker or a neophyte with glossophobia, the fear of speaking in public, there are basic strategies you can employ to ensure your presentation is smooth, well-crafted and ...

Oral presentations will be scheduled in one hour time blocks between 8:45 AM and 1:00 PM in the Campus Center and SAU. Presentations will be grouped by theme or topic area. Presenters will be notified ...

Novel combination with neoadjuvant eftilagimod alfa (efti) achieves significant 51.5% tumour hyalinization/fibrosis across ...

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced an oral presentation on ...

Grit Biotherapeutics Co., Ltd. (Grit Bio), a leading clinical-stage biopharmaceutical company pioneering next-generation ...

Informal Providers—Ground Realities in South Asian Association for Regional Cooperation Nations: Toward Better Cancer Primary Care: A Narrative Review Hidden oral cancer sites and residence in ...

LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on the research and development of ...